**Core Concept**
Acute hyperkalemia requires immediate intervention to prevent cardiac complications. The goal is to rapidly decrease serum potassium levels or shift potassium into cells, thereby reducing its cardiac toxicity.

**Why the Correct Answer is Right**
In emergency management of acute hyperkalemia, glucose with insulin is administered to drive potassium into cells. This is achieved through the sodium-potassium ATPase pump, which is activated by insulin, thereby decreasing serum potassium levels. Additionally, calcium gluconate is given to stabilize cardiac membranes and prevent arrhythmias. Beta-2 agonists like albuterol also help by driving potassium into cells. However, the correct answer is not one of these drugs.

**Why Each Wrong Option is Incorrect**
**Option A:** This option could potentially be correct, but without the actual drug listed, we can only assume it might be a treatment for hyperkalemia. However, if it is indeed a treatment, it should be one of the drugs we've already discussed.
**Option B:** This option is potentially incorrect as it might not be a standard emergency treatment for hyperkalemia, or it could be a treatment for a different condition altogether.
**Option C:** Like Option A, without the actual drug listed, we can only speculate. However, if it is indeed a treatment, it should be one of the drugs we've already discussed.

**Clinical Pearl / High-Yield Fact**
In the emergency management of acute hyperkalemia, it is essential to remember the "ABCDE" approach: **A**lbuterol, **B**eta-2 agonist; **C**alcium gluconate; **D**extrose with insulin; and **E**lectrolyte replacement.

**Correct Answer:** D.